Potential roles of insulin and IGF-1 in Alzheimer's disease

Trends in Neurosciences

Volumn 26, Issue 8, 2003, Pages 404-406

  Gasparini, Laura ^a   Xu, Huaxi ^b,c  

^a NicOx Research Institute   (Italy)

^b ROCKEFELLER UNIVERSITY   (United States)

^c BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; SOMATOMEDIN C; TAU PROTEIN;

AGING; ALZHEIMER DISEASE; CAENORHABDITIS ELEGANS; CELL ACTIVITY; DROSOPHILA; HORMONE ACTION; HUMAN; METABOLIC BALANCE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SHORT SURVEY; SIGNAL TRANSDUCTION; AMYLOIDOSIS; METABOLISM; NEUROFIBRILLARY TANGLE; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; REVIEW;

AGING; ALZHEIMER DISEASE; AMYLOIDOSIS; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; NEUROFIBRILLARY TANGLES; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TAU PROTEINS;

EID: 0142026832     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(03)00163-2     Document Type: Short Survey

References (27)

1. Kenyon C. A conserved regulatory system for aging. Cell. 105:2001;165-168.
2. Holzenberger M., et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature. 421:2003;182-187.
3. Torres-Aleman I. Serum growth factors and neuroprotective surveillance. Mol. Neurobiol. 21:2000;153-160.
4. Schulingkamp R.J., et al. Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci. Behav. Rev. 24:2000;855-872.
5. Frolich L., et al. Brain insulin and insulin receptors in aging and sporadic Alzheimer disease. J. Neural Transm. 105:1998;423-438.
6. Craft S., et al. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease. Neurology. 50:1998;164-168.
7. Kern W., et al. Role of insulin in Alzheimer's disease: approaches emerging from basic animal research and neurocognitive studies in humans. Drug Dev. Res. 56:2002;511-525.
8. Gasparini L., et al. Does insulin dysfunction play a role in Alzheimer's disease? Trends Pharmacol. Sci. 23:2002;288-293.
9. Citron M. Alzheimer's disease: treatments in discovery and development. Nat. Neurosci. 5:2002;1055-1057.
10. Xu H., et al. Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides. Nat. Med. 4:1998;447-451.
11. Gasparini L., et al. Stimulation of β-amyloid precursor protein trafficking by insulin reduces intraneuronal β-amyloid and requires mitogen-activated protein kinase signalling. J. Neurosci. 21:2001;2561-2570.
12. Carro E., et al. Serum insulin growth factor 1 regulates brain amyloid-β levels. Nat. Med. 8:2002;1390-1397.
13. Selkoe D.J. Clearing the brain's cobwebs. Neuron. 32:2001;177-180.
14. Hsiao K., et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
15. Pratico D., Trojanowski J.Q. Inflammatory hypothesis: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets? Neurobiol. Aging. 21:2000;441-445.
16. Hong M., Lee V.M.-Y. Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J. Biol. Chem. 272:1997;19547-19553.
17. Lesort M., et al. Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3β and Fyn tyrosine kinase. J. Neurochem. 72:1999;576-584.
18. Lesort M., Johnson G.V.W. Insulin-like growth factor-1 and insulin mediate transient site-selective increases in tau phosphorylation in primary cortical neurons. Neuroscience. 99:2000;305-316.
19. Schubert, M. et al. Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. J. Neurosci. (in press).
20. Lee V.M.-Y. Tauists and βaptists united - well almost! Science. 293:2001;1446-1447.
21. Venters H.D., et al. Tumor necrosis factorα and insulin-like growth factor-1 in the brain: is the whole greater than the sum of its parts? J. Neuroimmunol. 119:2001;151-165.
22. Åberg M.A.I., et al. Peripheral infusion of IGF-1 induces neurogenesis in the adult rat hippocampus. J. Neurosci. 20:2000;2896-2903.
23. Trejo J.L., et al. Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J. Neurosci. 21:2001;1628-1634.
24. Pons S., Torres-Aleman I. Insulin-like growth factor-1 stimulates dephosphorylation of IkB through the serine phosphatase calcineurin (protein phosphatase 2B). J. Biol. Chem. 275:2000;38620-38625.
25. Born J., et al. Sniffing neuropeptides: a transnasal approach to the human brain. Nat. Neurosci. 5:2002;514-516.
26. Air E.L., et al. Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity. Nat. Med. 8:2002;179-183.
27. Loddick S., et al. Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke. Proc. Natl. Acad. Sci. U. S. A. 95:1998;1894-1898.